TSO3
Company

Last deal

$20M

Amount

Post-IPO Debt

Stage

01.08.2018

Date

2

all rounds

$20.1M

Total amount

General

About Company
TSO3 develops innovative low temperature sterile reprocessing solutions for medical devices.

Industry

Sector :

Subsector :

founded date

01.01.1998

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Debt

IPO status

Private

Description

Founded in 1998, TSO3 offers unique sterilization processes using ozone as the sterilizing agent, providing significant cost savings, enhanced safety, and environmental benefits. The company focuses on the sale, production, maintenance, research, development, and licensing of sterilization processes, consumable supplies, and accessories for heat and moisture-sensitive medical devices. Their products offer advantageous alternatives to traditional low-temperature sterilization and high-level disinfection methods, benefiting sterile processing areas in medical facilities.
Contacts